Phenylketonuria Treatment Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Phenylketonuria Treatment Market to 2027 - Global Analysis and Forecasts By Type (Drugs, Dietary Supplement); Route of Administration (Oral, Parental); End User (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00005220 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Phenylketonuria is a genetic disorder that results in production of certain artificial sweeteners such as phenylalanine in the body. This can cause intellectual disability and other serious health problems in the body.

MARKET DYNAMICS
The Phenylketonuria Treatment market is anticipated to grow in the forecast, owing to the factors such as increasing research and development of novel drugs, growing acquisitions and collaborations between key market players, approvals of new drugs and growing prevalence of PKU among the children.

MARKET SCOPE
The "Global Phenylketonuria Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Phenylketonuria Treatment market with detailed market segmentation by Type, Route of Administration, End User and geography. The global Phenylketonuria Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Phenylketonuria Treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Phenylketonuria Treatment market is segmented on the basis of Type, Route of Administration and End User. Based on Drugs the market is segmented into Drugs, Dietary Supplement. Based on Route of Administration the market is segmented into Oral and Parental. Based on End User the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Phenylketonuria Treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Phenylketonuria Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Phenylketonuria Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Phenylketonuria Treatment market in these regions.

MARKET PLAYERS
The reports cover key developments in the Phenylketonuria Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Phenylketonuria Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Phenylketonuria Treatment market in the global market. Below mentioned is the list of few companies engaged in the Phenylketonuria Treatment market.
The report also includes the profiles of Phenylketonuria Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Cigna
  • Mayo Foundation for Medical Education and Research
  • BioMarin
  • Codexis, Inc.
  • Erytech Pharma
  • SOM Innovation Biotech SL
  • Synthetic Biologics, Inc
  • American Gene Technologies Inc
  • Danone
  • Retrophin, Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Phenylketonuria Treatment Market - By Type
1.3.2 Phenylketonuria Treatment Market - By Route of Administration
1.3.3 Phenylketonuria Treatment Market - By End User
1.3.4 Phenylketonuria Treatment Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHENYLKETONURIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PHENYLKETONURIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PHENYLKETONURIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. PHENYLKETONURIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. PHENYLKETONURIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PHENYLKETONURIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DRUGS
7.3.1. Overview
7.3.2. Drugs Market Forecast and Analysis
7.4. DIETARY SUPPLEMENT
7.4.1. Overview
7.4.2. Dietary Supplement Market Forecast and Analysis
8. PHENYLKETONURIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. PARENTAL
8.4.1. Overview
8.4.2. Parental Market Forecast and Analysis
9. PHENYLKETONURIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. PHENYLKETONURIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Phenylketonuria Treatment Market Overview
10.1.2 North America Phenylketonuria Treatment Market Forecasts and Analysis
10.1.3 North America Phenylketonuria Treatment Market Forecasts and Analysis - By Type
10.1.4 North America Phenylketonuria Treatment Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Phenylketonuria Treatment Market Forecasts and Analysis - By End User
10.1.6 North America Phenylketonuria Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Phenylketonuria Treatment Market
10.1.6.1.1 United States Phenylketonuria Treatment Market by Type
10.1.6.1.2 United States Phenylketonuria Treatment Market by Route of Administration
10.1.6.1.3 United States Phenylketonuria Treatment Market by End User
10.1.6.2 Canada Phenylketonuria Treatment Market
10.1.6.2.1 Canada Phenylketonuria Treatment Market by Type
10.1.6.2.2 Canada Phenylketonuria Treatment Market by Route of Administration
10.1.6.2.3 Canada Phenylketonuria Treatment Market by End User
10.1.6.3 Mexico Phenylketonuria Treatment Market
10.1.6.3.1 Mexico Phenylketonuria Treatment Market by Type
10.1.6.3.2 Mexico Phenylketonuria Treatment Market by Route of Administration
10.1.6.3.3 Mexico Phenylketonuria Treatment Market by End User
10.2. EUROPE
10.2.1 Europe Phenylketonuria Treatment Market Overview
10.2.2 Europe Phenylketonuria Treatment Market Forecasts and Analysis
10.2.3 Europe Phenylketonuria Treatment Market Forecasts and Analysis - By Type
10.2.4 Europe Phenylketonuria Treatment Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Phenylketonuria Treatment Market Forecasts and Analysis - By End User
10.2.6 Europe Phenylketonuria Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Phenylketonuria Treatment Market
10.2.6.1.1 Germany Phenylketonuria Treatment Market by Type
10.2.6.1.2 Germany Phenylketonuria Treatment Market by Route of Administration
10.2.6.1.3 Germany Phenylketonuria Treatment Market by End User
10.2.6.2 France Phenylketonuria Treatment Market
10.2.6.2.1 France Phenylketonuria Treatment Market by Type
10.2.6.2.2 France Phenylketonuria Treatment Market by Route of Administration
10.2.6.2.3 France Phenylketonuria Treatment Market by End User
10.2.6.3 Italy Phenylketonuria Treatment Market
10.2.6.3.1 Italy Phenylketonuria Treatment Market by Type
10.2.6.3.2 Italy Phenylketonuria Treatment Market by Route of Administration
10.2.6.3.3 Italy Phenylketonuria Treatment Market by End User
10.2.6.4 Spain Phenylketonuria Treatment Market
10.2.6.4.1 Spain Phenylketonuria Treatment Market by Type
10.2.6.4.2 Spain Phenylketonuria Treatment Market by Route of Administration
10.2.6.4.3 Spain Phenylketonuria Treatment Market by End User
10.2.6.5 United Kingdom Phenylketonuria Treatment Market
10.2.6.5.1 United Kingdom Phenylketonuria Treatment Market by Type
10.2.6.5.2 United Kingdom Phenylketonuria Treatment Market by Route of Administration
10.2.6.5.3 United Kingdom Phenylketonuria Treatment Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Phenylketonuria Treatment Market Overview
10.3.2 Asia-Pacific Phenylketonuria Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Phenylketonuria Treatment Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Phenylketonuria Treatment Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Phenylketonuria Treatment Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Phenylketonuria Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Phenylketonuria Treatment Market
10.3.6.1.1 Australia Phenylketonuria Treatment Market by Type
10.3.6.1.2 Australia Phenylketonuria Treatment Market by Route of Administration
10.3.6.1.3 Australia Phenylketonuria Treatment Market by End User
10.3.6.2 China Phenylketonuria Treatment Market
10.3.6.2.1 China Phenylketonuria Treatment Market by Type
10.3.6.2.2 China Phenylketonuria Treatment Market by Route of Administration
10.3.6.2.3 China Phenylketonuria Treatment Market by End User
10.3.6.3 India Phenylketonuria Treatment Market
10.3.6.3.1 India Phenylketonuria Treatment Market by Type
10.3.6.3.2 India Phenylketonuria Treatment Market by Route of Administration
10.3.6.3.3 India Phenylketonuria Treatment Market by End User
10.3.6.4 Japan Phenylketonuria Treatment Market
10.3.6.4.1 Japan Phenylketonuria Treatment Market by Type
10.3.6.4.2 Japan Phenylketonuria Treatment Market by Route of Administration
10.3.6.4.3 Japan Phenylketonuria Treatment Market by End User
10.3.6.5 South Korea Phenylketonuria Treatment Market
10.3.6.5.1 South Korea Phenylketonuria Treatment Market by Type
10.3.6.5.2 South Korea Phenylketonuria Treatment Market by Route of Administration
10.3.6.5.3 South Korea Phenylketonuria Treatment Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Phenylketonuria Treatment Market Overview
10.4.2 Middle East and Africa Phenylketonuria Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Phenylketonuria Treatment Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Phenylketonuria Treatment Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Phenylketonuria Treatment Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Phenylketonuria Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Phenylketonuria Treatment Market
10.4.6.1.1 South Africa Phenylketonuria Treatment Market by Type
10.4.6.1.2 South Africa Phenylketonuria Treatment Market by Route of Administration
10.4.6.1.3 South Africa Phenylketonuria Treatment Market by End User
10.4.6.2 Saudi Arabia Phenylketonuria Treatment Market
10.4.6.2.1 Saudi Arabia Phenylketonuria Treatment Market by Type
10.4.6.2.2 Saudi Arabia Phenylketonuria Treatment Market by Route of Administration
10.4.6.2.3 Saudi Arabia Phenylketonuria Treatment Market by End User
10.4.6.3 U.A.E Phenylketonuria Treatment Market
10.4.6.3.1 U.A.E Phenylketonuria Treatment Market by Type
10.4.6.3.2 U.A.E Phenylketonuria Treatment Market by Route of Administration
10.4.6.3.3 U.A.E Phenylketonuria Treatment Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Phenylketonuria Treatment Market Overview
10.5.2 South and Central America Phenylketonuria Treatment Market Forecasts and Analysis
10.5.3 South and Central America Phenylketonuria Treatment Market Forecasts and Analysis - By Type
10.5.4 South and Central America Phenylketonuria Treatment Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Phenylketonuria Treatment Market Forecasts and Analysis - By End User
10.5.6 South and Central America Phenylketonuria Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Phenylketonuria Treatment Market
10.5.6.1.1 Brazil Phenylketonuria Treatment Market by Type
10.5.6.1.2 Brazil Phenylketonuria Treatment Market by Route of Administration
10.5.6.1.3 Brazil Phenylketonuria Treatment Market by End User
10.5.6.2 Argentina Phenylketonuria Treatment Market
10.5.6.2.1 Argentina Phenylketonuria Treatment Market by Type
10.5.6.2.2 Argentina Phenylketonuria Treatment Market by Route of Administration
10.5.6.2.3 Argentina Phenylketonuria Treatment Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PHENYLKETONURIA TREATMENT MARKET, KEY COMPANY PROFILES
12.1. CIGNA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOMARIN
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CODEXIS, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ERYTECH PHARMA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. SOM INNOVATION BIOTECH SL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SYNTHETIC BIOLOGICS, INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AMERICAN GENE TECHNOLOGIES INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. DANONE
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. RETROPHIN, INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies


- Cigna
- Mayo Foundation for Medical Education and Research
- BioMarin
- Codexis, Inc.
- Erytech Pharma
- SOM Innovation Biotech SL
- Synthetic Biologics, Inc
- American Gene Technologies Inc
- Danone
- Retrophin, Inc